Vefora, Getug-Afu V06 Study: Randomized Multicenter Phase Ii/Iii Trial Of Fractionated Cisplatin (Ci)/Gemcitabine (G) Or Carboplatin (Ca)/G In Patients (Pts) With Advanced Urothelial Cancer (Uc) With Impaired Renal Function (Irf)-Results Of A Planned Interim Analysis

JOURNAL OF CLINICAL ONCOLOGY(2020)

Cited 4|Views7
No score
Abstract
461Background: Standard treatment for advanced UC is chemotherapy (CT) combining CI and G. 70% of pts with UC are over 65 and 40% of them are unfit for CI because of IRF or comorbidities. CA replac...
More
Translated text
Key words
advanced urothelial cancer,fractionated cisplatin,carboplatin,impaired renal function,getug-afu
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined